• Have a question?
    Open from 8am to 7pm Monday to Friday    Call customer services
    0345 54 32 600


| Print

Glaukos Corp (GKOS)

Sell: $75.80|Buy: $126.00|Change: 1.33 (-1.16%)

This share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPP

Company profile

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

Address

One Glaukos Way
Aliso Viejo
CA
USA
92656

Telephone

+1 949 3679600

Website

https://www.glaukos.com

Sector 

Healthcare

Forecast key dates

NameKey Date
Glaukos Corp Third Quarter Earnings Conference Call for 20262026-10-29T16:30:00
Glaukos Corp Third Quarter Earnings Results for 20262026-10-29T00:00:00
Glaukos Corp Second Quarter Earnings Conference Call for 20262026-07-30T16:30:00
Glaukos Corp Second Quarter Earnings Results for 20262026-07-30T00:00:00
Glaukos Corp Annual General Meeting for 20262026-05-29T09:00:00
Glaukos Corp First Quarter Earnings Conference Call for 20262026-04-30T16:30:00
Glaukos Corp First Quarter Earnings Results for 20262026-04-30T00:00:00
Glaukos Corp Annual Report for 20252026-02-25T00:00:00
Glaukos Corp Fourth Quarter Earnings Conference Call for 20252026-02-20T16:30:00
Glaukos Corp Fourth Quarter Earnings Results for 20252026-02-20T00:00:00
J.P. Morgan Healthcare Conference2026-01-13T16:30:00

Previous key dates

NameKey Date
J.P. Morgan Healthcare Conference2026-01-13T16:30:00
Citi Global Healthcare Conference2025-12-03T13:45:00
Stephens Annual Investment Conference2025-11-18T10:00:00
Stifel Healthcare Conference2025-11-12T13:20:00
UBS Global Healthcare Conference2025-11-11T10:15:00
Glaukos Corp Third Quarter Earnings Conference Call for 20252025-10-29T16:30:00
Glaukos Corp Third Quarter Earnings Results for 20252025-10-29T00:00:00
Glaukos Corp Second Quarter Earnings Conference Call for 20252025-07-30T16:30:00
Glaukos Corp Second Quarter Earnings Results for 20252025-07-30T00:00:00
Jefferies Global Healthcare Conference2025-06-04T20:45:00
William Blair 45th Annual Growth Stock Conference2025-06-03T13:40:00
Glaukos Corp Annual General Meeting for 20252025-05-29T09:00:00
Stifel 2025 Virtual Ophthalmology2025-05-27T12:30:00
Glaukos Corp First Quarter Earnings Conference Call for 20252025-04-30T16:30:00
Glaukos Corp First Quarter Earnings Results for 20252025-04-30T00:00:00
Glaukos Corp Annual Report for 20242025-02-25T00:00:00
Glaukos Corp Fourth Quarter Earnings Conference Call for 20242025-02-20T16:30:00
Glaukos Corp Fourth Quarter Earnings Result for 20242025-02-20T00:00:00
43rd Annual J.P. Morgan Healthcare Conference2025-01-14T17:15:00

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2026 AJ Bell. All rights reserved.